Hlb Genex Inc. logo

Hlb Genex Inc. (187420)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
1,988. 00
+218
+12.3164%
84.06B Market Cap
- P/E Ratio
- Div Yield
769,787 Volume
- Eps
1,770
Previous Close
Add Transaction
Day Range
1,701 2,135
Year Range
1,323 3,680
Want to track 187420 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

187420 closed today higher at ₩1,988, an increase of 12.3164% from yesterday's close, completing a monthly decrease of -2.069% or -₩42. Over the past 12 months, 187420 stock lost -25.4034%.
187420 is not paying dividends to its shareholders.
Hlb Genex Inc. has completed 1 stock splits, with the recent split occurring on Mar 19, 2018.
The company's stock is traded on one exchange.

187420 Chart

People also search for

Tk Chemical Corp.
1,664
+0.4225%
H.S. Industries Co. Ltd.
2,595
+1.1696%
Motrex Co. Ltd.
5,300
+1.7274%
Digital Daesung Co., Ltd.
8,420
+0.9592%
JTC Inc.
4,160
+1.836%

Hlb Genex Inc. (187420) FAQ

What is the stock price today?

The current price is ₩1,988.00.

On which exchange is it traded?

Hlb Genex Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 187420.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 84.06B.

Has Hlb Genex Inc. ever had a stock split?

Hlb Genex Inc. had 1 splits and the recent split was on Mar 19, 2018.

Hlb Genex Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
74 Employees
- Last Dividend
19 Mar 2018 Last Split
- IPO Date

Overview

GenoFocus, Inc. is a company dedicated to the research, development, production, and sales of enzymes and fermentation products, serving customers both in South Korea and internationally. The company, which was founded in the year 2000 and is headquartered in Daejeon, South Korea, has carved a niche for itself in the biotechnology industry by focusing on the creation of specialized enzymes and bioproducts. GenoFocus's operations encompass a broad spectrum, from the advanced research and development of enzyme technologies to the importing and exporting of their novel products. This multifaceted approach positions GenoFocus as a significant player in the global market for industrial enzymes and health care ingredients.

Products and Services

  • Industrial Special Enzyme

    Includes a variety of enzymes developed for specific industrial applications. Notably, lactase, which is marketed for its ability to prevent pathogen infection/proliferation and food poisoning, alongside addressing allergies and atopy. Another significant product is Proteinase K, a recombinant protease from the fungal strain Tritirachium album, widely used in the biotech industry for isolating DNA from cells and tissues, removing DNase and RNase for pure DNA and RNA extraction, and enhancing PCR cloning efficiency. Catalase, known for its role in decomposing hydrogen peroxide, is utilized across several industries, including semiconductor water treatment, textile processing, and HPPO (hydrogen peroxide to propylene oxide) manufacturing processes.

  • Bio-Health Care Ingredient

    GenoFocus has developed and offers bio-healthcare ingredients, such as N-phytosphingosine, which is used as a cosmetic material to aid in skin barrier function improvement. Additionally, Vitamin K2 is offered for its benefits to bone and cardiovascular health, reflecting the company's expansion into health and wellness products.

  • Superoxide Dismutase Development

    GenoFocus is also involved in the development of superoxide dismutase, an antioxidant enzyme that is currently in preclinical trial. This product highlights GenoFocus, Inc.'s commitment to advancing healthcare solutions through innovative biotechnology research.

Contact Information

Address: 65 Techno 1-ro
Phone: 82 4 2862 4483